Delivery Order SPE2DB22D2206-SPE2DB25FJA89
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML, a pharmaceutical product, with a firm fixed price structure. The contract was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a delivery order valued at $63,291.20 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen/mL pharmaceutical supplies. This firm fixed price, competitively awarded delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $15,346.24 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pharmaceutical product on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's Conshohocken, Pennsylvania facility. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $50,801.12 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of SKYRIZI 150 mg/mL pen/mL, a pharmaceutical product used to treat inflammatory conditions. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 24, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML, a prescription pharmaceutical product, with a ceiling value of $26,843.24. This firm fixed-price delivery order was awarded competitively with no set-aside designation on August 5, 2025, with an ultimate completion date of August 6, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $78,984.77 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pen-ml, a pharmaceutical product for federal medical procurement needs. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement through...
- The Defense Logistics Agency awarded a delivery order valued at $37,510.45 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL, a pharmaceutical product. This firm fixed price contract, issued on July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply agreement running through December 2026. The contract was competitively awarded...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $44,915.10 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of SKYRIZI 150 mg/mL pen/mL, a specialty pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, is a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $28,396.90 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml, a pharmaceutical product. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA89Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,368.86 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml, a pharmaceutical product, on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to military and veteran healthcare systems. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, the company has demonstrated capability to meet federal procurement requirements through open competition. The DLA Troop Support Medical IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including service to the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.4k | 7/23/25 |